- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- Movmedix gets FDA nod for third-gen synthetic shoulder implant
Movmedix has received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant, marking the company's first U.S. regulatory approval and enabling the launch of the shoulder repair system in the United States. The implant is designed to treat acromioclavicular (ACJ) joint inj
- Neo Medical launches access platform for minimally invasive spine surgery
Neo Medical has launched its Neo Instant MIS Access platform in the United States, expanding its minimally invasive spine surgery offering for thoracic, lumbar, and sacral procedures. The system is designed to simplify posterior MIS workflows by removing reliance on capital equipment, reusable instr
- First patient enrolled in study of Reflow Medical’s Spur system
Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients with chronic limb-threatening ischemia (CLTI). The single-center study at the Medical University of Graz will enroll up to 4
- Boustead acquires majority stake in urology robotics company UroMedTech
Boustead Singapore Limited has acquired a 60% stake in UroMedTech Pte Ltd through a S$6 million equity investment, expanding its healthcare technology portfolio. UroMedTech develops the UroMaster robotic platform for prostate cancer diagnosis, which is approved in Singapore, Malaysia, Australia, and
- Median Technologies’ eyonis LCS obtains CE marking
Median Technologies has announced that its AI-powered software, eyonis® LCS, has obtained CE marking as a Class IIb medical device. Granted by the French notified body GMED, this certification confirms compliance with European standards for patient safety and clinical efficacy, allowing the company
- Materna Medical closes $5 Million B3 financing to fuel growth
Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with participation from existing investors. This new capital positions the com
- Francis Medical announces publication of VAPOR 2 pivotal trial results
Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology , showcasing highly positive results for its Vanquish Water Vapor Ablation System. The trial evaluated the first 110 patients diagnosed with localized, intermediate-risk prostate cancer a
- Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences
Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140 million. Under the terms of the agreement, Zimmer Biomet will provide an upfront payment of $70 million, with the remaining $70 million structured as potentia
- Novocure earns CE mark for Optune Pax pancreatic cancer treatment device
Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced pancreatic cancer. The portable device works by delivering noninvasive, alternating electrical fields- known as Tumor Treating Fields (TTFields) -
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
Movmedix has received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant, marking the company's first U.S. regulatory approval and enabling the launch of the shoulder repair system in the United States.
The implant is designed to treat acromioclavicular (ACJ) joint inju
Neo Medical has launched its Neo Instant MIS Access platform in the United States, expanding its minimally invasive spine surgery offering for thoracic, lumbar, and sacral procedures.
The system is designed to simplify posterior MIS workflows by removing reliance on capital equipment, reusable instru
Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients with chronic limb-threatening ischemia (CLTI).
The single-center study at the Medical University of Graz will enroll up to 40
Boustead Singapore Limited has acquired a 60% stake in UroMedTech Pte Ltd through a S$6 million equity investment, expanding its healthcare technology portfolio.
UroMedTech develops the UroMaster robotic platform for prostate cancer diagnosis, which is approved in Singapore, Malaysia, Australia, and
Median Technologies has announced that its AI-powered software, eyonis® LCS, has obtained CE marking as a Class IIb medical device. Granted by the French notified body GMED, this certification confirms compliance with European standards for patient safety and clinical efficacy, allowing the company
Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with participation from existing investors. This new capital positions the com
Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for its Vanquish Water Vapor Ablation System. The trial evaluated the first 110 patients diagnosed with localized, intermediate-risk prostate cancer ac
Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140 million. Under the terms of the agreement, Zimmer Biomet will provide an upfront payment of $70 million, with the remaining $70 million structured as potentia
Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced pancreatic cancer. The portable device works by delivering noninvasive, alternating electrical fields- known as Tumor Treating Fields (TTFields) -